Public research preview
Rob Bresnahan, Representative disclosure: Thermo Fisher Scientific Inc Common Stock (TMO)
Disclosed a sell transaction in Thermo Fisher Scientific Inc Common Stock (TMO). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.
This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.
Evidence passport
Official-source context and parser confidence before any simulation or alert decision.
- Source
- House STOCK Act disclosures
- Published
- 28 Apr 2025, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%
- Filing delay
- 20 days
Timeline
Transaction date
8 Apr 2025
Public disclosure
28 Apr 2025
Now
Tracked today
Filing delay: 20 days
Price movement
Complete coverage
- Provider
- Yahoo Finance daily close
- Fetched
- 11 Jun 2026
Stock path
TMO from pre-transaction context through latest close.
Transaction
8 Apr 2025 · 417,773 USD · Not public yet
System decision
Would not buy — The strategy's filters reject this signal. Failed filters: Buy disclosure.
- Not public yet
- Would not buy
- Observed transaction close
- 417,773
- Observed disclosure close
- 419,795
- Observed latest close
- 473,57
- Pre-disclosure move
- +0.5%
- Post-disclosure move
- +12.8%
- Market-adjusted move
- -18.7%
- Pre-disclosure peak run-up
- +8.2%
- Retrace from peak
- -7.1%
Why Copy Window is Probably too late
Supporting factors
- Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
- Reported amount is $15,001 - $50,000.
- Post-disclosure move is calculated from Yahoo Finance daily close daily closes.
Cautions
- Yahoo Finance daily close coverage is end-of-day and should be verified against the official price source.
- Review the original source document before making any investment decision.
Source document
House STOCK Act disclosures, published 28 Apr 2025, 00.00
- Parser confidence
- 94%
- Instrument mapping
- 95%